Advertisement
Screener

Vir Biotechnology, Inc. (VIR) Subsidiaries

Vir Biotechnology, Inc. Subsidiaries

Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (4 lists). Names and jurisdictions are as filed.

  • 2026-02-23: Subsidiary Agenovir Corporation; Jurisdiction Delaware.
  • 2026-02-23: Subsidiary Encentrio Therapeutics, Inc.; Jurisdiction Delaware.
  • 2026-02-23: Subsidiary Humabs BioMed SA; Jurisdiction Switzerland.
  • 2026-02-23: Subsidiary TomegaVax, Inc.; Jurisdiction Delaware.
Annual report filedSubsidiaryJurisdiction
2026-02-23Agenovir CorporationDelaware
2026-02-23Encentrio Therapeutics, Inc.Delaware
2026-02-23Humabs BioMed SASwitzerland
2026-02-23TomegaVax, Inc.Delaware
2026-02-23Vir AU Biotechnology Pty Ltd.Australia
2025-02-27Agenovir CorporationDelaware
2025-02-27Encentrio Therapeutics, Inc.Delaware
2025-02-27Humabs BioMed SASwitzerland
2025-02-27TomegaVax, Inc.Delaware
2025-02-27Vir AU Biotechnology Pty Ltd.Australia
2024-02-26Agenovir CorporationDelaware
2024-02-26Encentrio Therapeutics, Inc.Delaware
2024-02-26Encentrio Therapeutics International GmbHSwitzerland
2024-02-26Humabs BioMed SASwitzerland
2024-02-26TomegaVax, Inc.Delaware
2024-02-26Vir AU Biotechnology Pty Ltd.Australia
2024-02-26Vir Biotechnology International GmbHSwitzerland
2024-02-26Vir Predictive Medicine, Inc.Delaware
2024-02-26VirAb, Inc.Delaware
2023-02-28Agenovir Corporation
2023-02-28Encentrio Therapeutics, Inc.
2023-02-28Encentrio Therapeutics International GmbH
2023-02-28Humabs BioMed SA
2023-02-28Statera Health, LLC
2023-02-28TomegaVax, Inc.
2023-02-28Vir AU Biotechnology Pty Ltd.
2023-02-28Vir Biotechnology International GmbH
2023-02-28Vir Predictive Medicine, Inc.
2023-02-28VirAb, Inc.
2023-02-28Delaware
2023-02-28Delaware
2023-02-28Switzerland
2023-02-28Switzerland
2023-02-28Delaware
2023-02-28Delaware
2023-02-28Australia
2023-02-28Switzerland
2023-02-28Delaware
2023-02-28Delaware

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Vericel Corp (VCEL)United States$2.011B93.97
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40